Tel Aviv University
Tel Aviv, 6997801, Israel
NCT Number: NCT05294848
Military service in combat units entails exposure to traumatic events that require mental adjustment. To develop and efficiently apply attention bias modification interventions aimed at enhancing soldiers' mental resilience, it is essential to test the efficiency of such training programs in RCTs. The purpose of the current study is to examine the efficiency of a new attention eye-tracking-based training protocol, in comparison to an RT-based training protocol, and to a control group, in reducing risk for post-trauma symptoms in combat deployed soldiers.
Looking for future studies?
Notify Me18 year and older
Male
Interventional
Not applicable
Tel Aviv, 6997801, Israel
Following the explanation to participants regarding the study process, those who give written consent to participate will be randomly placed into one of three groups: GCFT (N=180), ABMT (N=180), and a neutral control group - RT-based task (N=180). The study will include 3 measurement points: before attention training (in basic training before deployment), after attention training (in basic training camp, still before deployment), and after a combat deployment cycle (6-12 months - to be determined based on the military deployment mission of the participants). In each measurement point, the participants will complete computerized tasks to measure attention and will complete self-report questionnaires.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Feedback according to participants' viewing patterns, in order to modify their attention toward threat stimuli.
Attention training via repeated trials of a dot-probe task intended to direct attention toward threat stimuli using threat and neutral face stimuli.
Dot-probe task using only neutral stimuli with no training toward threat
Time frame: Change from baseline Post-Combat PTSD Symptoms at approximately 1.5 years
Score on on self-report questionnaire Posttraumatic stress disorder checklist for DSM-5 (PCL-5). The total score, ranging from 0 to 80, reflects PTSD symptom severity, with higher scores representing greater severity.
Time frame: Change from baseline Post-Combat General Anxiety Symptoms at approximately 1.5 years
Score on self-report questionnaire Generalized Anxiety Disorder questionnaire (GAD-7). The total score, ranging from 0 to 21, reflects GAD symptom severity, with higher scores representing greater severity.
Time frame: Change from baseline Post-Combat Depression Symptoms at approximately 1.5 years
Score on self-report Patient Health Questionnaire 9 (PHQ-9). The total score, ranging from 0-27, reflects severity of depressive symptoms, with higher scores representing greater severity
Time frame: Change from baseline Attention Bias within 6 months of baseline measurement
Change in Attention Bias will be assessed with a response-time based dot-probe task.
Time frame: Change from baseline Attention Bias within 6 months of baseline measurement
Change in Subjective Attention Bias will be assessed with a self-reported attention bias using the Attention Bias Questionnaire (ABQ). The total score, ranging from 0 to 36, represents threat-related attention bias, with higher scores representing greater bias toward threat.
Time frame: Change from baseline Attention Bias within 6 months of baseline measurement
Change in Attention Bias will also be assessed with an eye-tracking task.
Tel Aviv University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06282146
Anxiety Disorders, Behavior
Boston, Massachusetts, United States
View Trial DetailsNCT05228964
Anxiety Disorders, Behavior
Austin, Texas, United States
View Trial DetailsNCT06618404
Anxiety Disorders, Behavior
Reading, Berkshire, United Kingdom
View Trial DetailsNCT04965740
Anxiety, Anxiety Disorders
Surrey, British Columbia, Canada
View Trial Details